0001635884-15-000001.txt : 20150309 0001635884-15-000001.hdr.sgml : 20150309 20150309121234 ACCESSION NUMBER: 0001635884-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150309 DATE AS OF CHANGE: 20150309 EFFECTIVENESS DATE: 20150309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NSC Biotech Venture Fund I LLC CENTRAL INDEX KEY: 0001635884 IRS NUMBER: 472345018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-235439 FILM NUMBER: 15684271 BUSINESS ADDRESS: STREET 1: 410 PARK AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2123802819 MAIL ADDRESS: STREET 1: 410 PARK AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0707 D LIVE 0001635884 NSC Biotech Venture Fund I LLC 410 PARK AVENUE, 14TH FLOOR NEW YORK NY NEW YORK 10022 2123802819 DELAWARE None None Limited Liability Company true 2014 Michael Anthony Mullen 410 Park Avenue, 14th Floor New York NY NEW YORK 10022 Executive Officer Mark Goldwasser 410 Park Avenue New York NY NEW YORK 10022 Executive Officer Investing Decline to Disclose 06b false 2015-02-27 false true false 25000 National Securities Corporation 7569 N/A None 410 Park Avenue New York NY NEW YORK 10022 AZ ARIZONA AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA ID IDAHO IL ILLINOIS IN INDIANA IA IOWA KS KANSAS ME MAINE MD MARYLAND MN MINNESOTA MS MISSISSIPPI MO MISSOURI NE NEBRASKA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA TX TEXAS VA VIRGINIA WA WASHINGTON WI WISCONSIN false 10000000 10000000 0 false 88 800000 0 0 false NSC Biotech Venture Fund I LLC Michael A. Mullen Michael A. Mullen Managers Manager 2015-03-09